As GLP-1 receptor agonists like Ozempic®, Wegovy®, and Mounjaro® become increasingly common in both diabetes and weight loss management, a new clinical challenge is emerging: patients are reporting gastrointestinal symptoms that are difficult to differentiate from underlying disorders. For gastroenterologists and colorectal specialists, anorectal manometry (ARM) is becoming a crucial tool to evaluate and manage these symptoms with greater precision.
Read MoreAs the demand for comprehensive, data-driven GI care increases, more clinics are recognizing the value of adding Anorectal Manometry (ARM) to their diagnostic offering. ARM, particularly when performed with a streamlined system like mcompass®, supports more accurate diagnoses and boosts clinic efficiency and revenue potential. If you’re wondering whether now is the right time to grow your practice with ARM, here are three clear signs to look for:
Read MoreMany patients who experience GI discomfort after treatment have already tried dietary changes, medications, and undergone routine screenings like colonoscopies. Naturally, frustration occurs when they find the source of their discomfort remains unresolved. So what could be missing?
Read MoreEarly detection and comprehensive colorectal health care are essential for improving patient outcomes and quality of life. Many patients experience persistent GI symptoms that require more than just structural testing like colonoscopy and imaging—they need functional assessments to uncover the underlying cause of their discomfort and concerns.
Read MoreChoosing the right diagnostic tool is crucial for accurately identifying anorectal disorders. While various methods are available, Anorectal Manometry (ARM) offers unique benefits that make it a valuable tool for specific cases.
Read MoreGet in touch with us to learn how our products can make an impact on your practice.
Aug 8 - Aug 10, 2025
Minneapolis, MN
Sep 12 - Sep 14, 2025
Orlando, FL
Sep 12 - Sep 14, 2025
Houston, TX
Oct 24 - Oct 29, 2025
Phoenix, AZ